This may change figures of future epidemiological studies on SUD and BD comorbidity to some degree. Dual diagnosis requires appropriate assessment to differentiate between primary bipolar symptoms and substance-induced mood disorders. Chronic alcohol consumption can exacerbate the symptoms of bipolar disorder, increase hospitalisation and reduce the effectiveness of treatment. Chronic alcohol consumption over a long period of time impairs the brain’s ability to control emotions well. The high prevalence of co-occurrence of bipolar disorder and alcoholism emphasises the underlying links.
For people with bipolar disorder, alcohol acts as a central nervous system depressant, initially producing a sedative effect that might temporarily mask symptoms like anxiety or agitation. However, this is short-lived, as alcohol interferes with neurotransmitters such as dopamine and serotonin, which play a pivotal role in regulating mood. Over time, this Rolex replica interference can lead to heightened emotional volatility, making it harder for individuals to maintain stable moods. Having a family history of either bipolar disorder or alcohol use disorder increases your risk of developing both. Research suggests that certain genetic variations affect brain chemistry related to mood regulation and substance processing. Thus, there is growing evidence that the presence of a concomitant alcohol use disorder may adversely affect the course of bipolar disorder, and the order of onset of the two disorders has prognostic implications.
Bipolar disorder and alcohol use disorder represent a significant comorbid population, which is significantly worse than either diagnosis alone in presentation, duration, co-morbidity, cost, suicide rate, and poor response to treatment. They share some common characteristics in relation to genetic background, neuroimaging findings, and some biochemical findings. There are a number of pharmacotherapy trials, and psychotherapy trials that can aid programme development.
In people with bipolar disorder, this contributes to impaired mood regulation and recovery processes. Long-term alcohol use in individuals with bipolar disorder can lead to poorer treatment outcomes, increased hospitalization, and a higher risk of substance use disorder. Several factors explain the high rate of co-occurrence between alcohol use disorder and bipolar disorder, including genetic vulnerability, self-medication, impaired judgment during mania, and brain chemistry similarities. As a general rule, it seems appropriate to diagnose bipolar disorder if the symptoms clearly occur before the onset of the alcoholism or if they persist during periods of sustained abstinence. The adequate amount of abstinence for diagnostic purposes has not been clearly defined.
Chronic alcohol consumption exacerbates depressive episodes by increasing withdrawal, the tendency to self-harm and suicidal thoughts. It may also deepen depressive phases, potentially resulting in a presentation similar to alcohol induced bipolar disorder ICD 10. Long-term alcohol abuse has a negative impact on cognitive performance, memory bipolar disorder and alcoholism relation and decision-making.
This interplay not only compromises treatment efficacy but also increases the risk of relapse. Patients must be educated about these risks and encouraged to avoid alcohol to maintain stability. Bipolar disorder, often called manic depression, is a mood disorder that is characterized by extreme fluctuations in mood from euphoria to severe depression, interspersed with periods of normal mood (i.e., euthymia). Bipolar disorder represents a significant public health problem, which often goes undiagnosed and untreated for lengthy periods. Bipolar disorder affects approximately 1 to 2 percent of the population and often starts in early adulthood. Acamprosate has also been evaluated in an open-label trial and a randomized controlled trial.
Chronic alcohol exposure impairs neurogenesis, particularly in the hippocampus, a region critical for mood regulation. This reduction in neuroplasticity can hinder the brain’s resilience to stress and mood fluctuations, potentially triggering bipolar symptoms. For individuals with bipolar disorder, these neurochemical and structural changes from alcohol use can create a vicious cycle, making it harder to manage the condition effectively. Serotonin, a neurotransmitter involved in mood stabilization, is also affected by alcohol use. Chronic alcohol consumption depletes serotonin levels, which can exacerbate mood instability in bipolar disorder. Serotonin dysregulation is particularly problematic during alcohol withdrawal, as it may contribute to irritability, anxiety, and depressive symptoms.
In summary, there is a continuous need for more research in order to develop evidence-based approaches for integrated treatment of this frequent comorbidity. Alcohol may have been used in the alcohol use disorder – bipolar disorder group to ease the strain and stress brought on by an irritable temperament, anxiousness, and organic problems, which resulted in the initial depressive episode. Alcohol drinking was a consequence of the intensity of mania in the bipolar disorder – alcohol use disorder group and stimulant use may have been the cause of the initial manic episode. There’s a chance that the routes that lead to alcohol use disorder – bipolar disorder or bipolar disorder – alcohol use disorder are different.
Additionally, the depressive effects of alcohol can deepen feelings of sadness or hopelessness, potentially prolonging or intensifying depressive episodes. Studies have shown that individuals with bipolar disorder who consume alcohol are more likely to experience rapid cycling, a pattern of frequent and severe mood episodes, compared to those who abstain. This cyclical pattern can be particularly destabilizing, making mood management more challenging. During manic episodes, alcohol may seem to slow down racing thoughts and reduce hyperactivity.
Many lack access to services and recommended interventions, especially in low- and middle-income countries (LMICs). Carbamazepine has been traditionally used in acute alcohol withdrawal to reduce the risk of seizures and ameliorate physical symptoms. However, there are no reliable data whether it is of any usefulness in the long-term treatment of BD + AUD. Carbamazepine is metabolized by the liver and can, by itself, induce an increase in liver transaminases (ALAT, ASAT, γGT) and, in rare cases, cause liver failure. The German S3 Guidelines for AUD (49) recommends cognitive behavioral therapy (CBT) as the best evidenced modality whereas there is no recommendation for other psychotherapies due to insufficient data. Whereas, the incidence of BD across countries and cultures is within a similar range, reported rates for AUD differ considerably due to cultural and religious diversity.
Both studies included also patients with other major mental health disorders, such as MDD and schizophrenia; thus, both do not supply information exclusively about changes in the course of BD (96, 97). Only a follow-up evaluation of the first study after 3 years specifically reports about 51 patients with BD and comorbid SUD, stating that taking part in the AST program has also improved quality of life (QoL) and diverse functionality measures (98). The OR for developing a SUD has been estimated 1.8 in patients with a lifetime MDD and 6.9 for those with a lifetime BD-I, compared with the general population (34), and prevalence rates for SUD are ~25–50% higher in BD-I than BD-II patients (26, 35). The latter appears to be mainly driven by illicit drugs (OR 7.46 in BD-I and 3.30 in BD-II) (28).
Alcohol use may worsen the clinical course of bipolar disorder, making it harder to treat. Some studies have evaluated the effects of valproate, lithium, and naltrexone, as well as psychosocial interventions, in treating alcoholic bipolar patients, but further research is needed. The relationship between bipolar disorder and substance abuse is complex and well-documented, with alcohol being one of the most commonly misused substances among individuals with this mental health condition. Research suggests that there is a strong bidirectional link between bipolar disorder and substance abuse, meaning that each can influence the onset, severity, and progression of the other. For instance, individuals with bipolar disorder are significantly more likely to develop a substance use disorder compared to the general population.
In a prospective cohort study, 232 comorbid patients with alcohol dependence and an affective disorder (among whom 102 were individuals with BDs), received inpatient treatment with cognitive behavioral therapy for 4 weeks (90). At 6-month follow-up both groups (depressive and bipolar patients) showed a significant reduction of alcohol consumption, but no difference was found between patients with unipolar and bipolar disorder. At 5-year follow-up, there was still a significant long-term benefit, particularly in those who engaged in post-discharge supportive therapy. Early abstinence predicted later abstinence, and a significant number of those who reduced their drinking by 6 months also achieved complete abstinence after 5 years (91).
Alcohol acts as a GABA agonist, enhancing inhibitory signaling, while simultaneously suppressing glutamate, an excitatory neurotransmitter. However, chronic alcohol use disrupts the balance between these systems, leading to neuroadaptation. In bipolar disorder, this imbalance can destabilize mood regulation, potentially triggering manic or depressive episodes. The question of whether alcohol can “trigger” bipolar disorder in individuals who were previously asymptomatic is more nuanced.
Available research on the use of lithium, valproate, and naltrexone for comorbid patients is reviewed below. O’Sullivan and colleagues (1988) found that alcoholics with bipolar disorder functioned better during a 2-year followup period than did primary alcoholics (i.e., those without comorbid mood disorders) or alcoholics with unipolar depression. This suggests that bipolar patients may use alcohol primarily as a means to medicate their affective symptoms, and if their bipolar symptoms are adequately treated, they are able to stop abusing alcohol. Hasin and colleagues (1989) found that patients with bipolar II disorder were likely to have an earlier remission from alcoholism compared with patients with schizoaffective disorder or bipolar I disorder. Researchers have also proposed that the presence of mania may precipitate or exacerbate alcoholism (Hasin et al. 1985). Psychosocial interventions have often been considered the mainstays of treatment for alcoholism and other substance use disorders.